BEHAB (Brain Enriched Hyaluronan Binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2293-2298

  Jaworski, Diane M ^a,b   Kelly, Gail M ^a   Piepmeier, Joseph M ^a   Hockfield, Susan ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID BINDING PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; CANCER INVASION; GLIOBLASTOMA; MARKER GENE; METASTASIS POTENTIAL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; ANIMALS; BRAIN NEOPLASMS; CARRIER PROTEINS; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; HYALURONIC ACID; IN SITU HYBRIDIZATION; LECTINS, C-TYPE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NERVE TISSUE PROTEINS; PROTEOCHONDROITIN SULFATES; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030009866     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Knudson, C. B., and Knudson, W Hyaluronan-binding proteins in development, tissue homeostasis and disease. FASEB J., 7: 1233-1241, 1993.
2. Turley, E. A., Hyaluronan and cell locomotion Cancer Metastasis Rev , 11: 21-30, 1992.
3. Jaworski, D M., Kelly, G. M., and Hockfield, S BEHAB, a new member of the proteoglycan tandem repeat family of hyaluronan binding proteins that is restricted to brain. J. Cell Biol., 125: 495-509, 1994.
4. Jaworski, D M., Kelly, G. M., and Hockfield, S The CNS specific hyaluronan-binding protein, BEHAB, is expressed in ventricular zones coincident with gliogenesis. J. Neurosci., 15. 1352-1362, 1995.
5. Chirgwin, J. M , Przybyla, A. E , MacDonald, R J., and Rutter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry, 18: 5294-5298, 1979.
6. Kleihues, P., Burger, P C., and Scheithauer, B. W. Histological typing of Tumours of Central Nervous System. p. 9. Geneva, Switzerland: World Health Organization, 1993
7. Kruse, C. A., Molleston, M C., Parks, E. P., Schlitz, P. M , Klemschmidt-DeMasters, B K , and Hickey, W. F A rat glioma model, CNS-1, with invasive characteristics similar 10 those of human gliomas: a comparison to 9L gliosarcoma. J. Neuro-oncol., 22: 191-200, 1994
8. Mercer, W. E., Shields, M. T , Amin, M., Sauve, G. J., Appella, E., Romano, J. W., and Ullrich, S. J Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci USA, 87: 6166-6170, 1990
9. Shimohama, S., Rosenberg, M B., Fagan, A. M., Wolff, J. A., Short, M. P., Breakfield, X O , Friedmann, T., and Gage, F H. Grafting genetically modified cells into the rat brain: characteristics of E. coli β-galactosidase as a reporter gene. Mol. Brain Res., 5: 271-278, 1989.
10. Yamada, H., Watanabe, K., Shimonaka, M., and Yamaguchi, Y Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family. J. Biol. Chem., 269: 10119-10126, 1994.
11. Seidenbecher, C. I., Richter, K., Rauch, U , Reinhard, F., Garner, C. C , and Gundelfinger, E. D. Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms. J. Biol. Chem., 270: 27206-27212, 1995.
12. Richardson, W. D., Pringle, N., Mosley, M J., Westermark, B , and Dubois-Dalc, M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell, 53: 309-319, 1988
13. Gomex-Pinilla, F , Vu, L., and Cotman, C. W Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo. J. Neurosci., 15: 2021-2029, 1995.
14. Muller, H W , Junghans, U , and Kappler, J. Astroglial neurotrophic and neurite-promoting factors Pharmacol. & Ther., 65: 1-18, 1995.
15. Collins, V. P., and James, C D. Gene and chromosomal alterations associated with the development of human gliomas FASEB J., 7: 926-930, 1993.
16. 1. Br. J Cancer, 70: 199-203, 1994
17. Nister, M., Libermann, T. A., Betholtz, C , Pettersson, M., Claesson-Welsh, L , Heldin, C-H., Schlessinger, J., and Westermark, B Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor α and their receptors in human malignant glioma cell lines Cancer Res., 48: 3910-3918, 1988.
18. Delpech, B , Delpech, A., Bruckner, G., Girard, N., and Maingonnat, C Hyaluronan and hyaluronectin in the nervous system. In D. Evered and J. Whelan (eds ), The Biology of Hyaluronan, pp. 208-232 Chichester, United Kingdom: John Wiley & Sons, 1989.
19. Delpech, B., Maingonnat, C , Girard, N., Chauzy, C., Maunoury, R., Olivier, A., Tayot, J., and Creissard, P. Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumor stroma Eur. J. Cancer, 29A: 1012-1017, 1993.
20. Pilkington, G. J. Tumor cell migration in the central nervous system. Brain Pathol., 4: 157-166, 1994.
21. Radotra, B., McCormick, D., and Crockard, A. CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components. Neuropathol. Appl Neurobiol , 20: 399-405, 1994.
22. Gunthert, U., Hofmann, M., Rudy, W , Reber, S , Zoller, M , Haussmann, I., Matzku, S , Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells Cell, 65: 13-24, 1991.
23. Hall, C. L., Yang, B., Yang, X , Zhang, S , Turley, M , Samuel, S., Lange, L. A., Wang, C , Curpen, G. D., Savani, R. C., Greenberg, A. H., and Turley, E. A. Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation Cell, 82: 19-28, 1995.
24. Knudson, W., Biswas, C., Li, Q., Nemec, R. E., and Toole, B. P. The role and regulation of tumor-associated hyaluronan. In: D. Evered and J Whelan (eds.), The Biology of Hyaluronan. Ciba Foundation Symposium 143, pp. 150-169, Chichester, United Kingdom: John Wiley & Sons, 1989.
25. Kuppner, M. C., Van Meir, E , Gauthier, T., Hamou, M-F., and de Tribolet, N. Differential expression of the CD44 molecule in human brain tumors. Int. J. Cancer, 50: 572-577, 1992
26. Bertrand, P., Girard, N., Delpech, B., Duval, C., D'Anjou, J., and Dauce, J. P. Hyaluronan (hyaluroruc acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int. J Cancer, 52. 1-6, 1992.
27. Yokozaki, H., Ito, R , Nakayama, H., Kuniyasu, H , Taruyama, K., and Tahara, E. Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett., 83: 229-234, 1994.
28. Culty, M , Shizari, M., Thompson, E W , and Underhill, C. B. Binding and degradation of hyaluronan by breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J. Cell. Physiol., 160. 275-286, 1994.
29. Penno, M. B., August, J. T , Baylin, S. B., Mabry, M , Linnoila, R. I., Lee, V. S., Croteau, D., Yang, X. L., and Rosada, C. Expression of CD44 in human lung tumors. Cancer Res., 54: 1381-1387, 1994.